Design, Synthesis and Biological Evaluation of Novel MDH Inhibitors Targeting Tumor Microenvironment
Citations

WEB OF SCIENCE

9
Citations

SCOPUS

9

초록

MDH1 and MDH2 enzymes play an important role in the survival of lung cancer. In this study, a novel series of dual MDH1/2 inhibitors for lung cancer was rationally designed and synthesized, and their SAR was carefully investigated. Among the tested compounds, compound 50 containing a piperidine ring displayed an improved growth inhibition of A549 and H460 lung cancer cell lines compared with LW1497. Compound 50 reduced the total ATP content in A549 cells in a dose-dependent manner; it also significantly suppressed the accumulation of hypoxia-inducible factor 1-alpha (HIF-1a) and the expression of HIF-1a target genes such as GLUT1 and pyruvate dehydrogenase kinase 1 (PDK1) in a dose-dependent manner. Furthermore, compound 50 inhibited HIF-1a-regulated CD73 expression under hypoxia in A549 lung cancer cells. Collectively, these results indicate that compound 50 may pave the way for the development of next-generation dual MDH1/2 inhibitors to target lung cancer.

키워드

MDH1/2inhibitorsHIF-1 alphalung cancerNICOTINAMIDE ADENINE-DINUCLEOTIDEMALATE-ASPARTATE SHUTTLEDEHYDROGENASECANCERGLUCOSEADAPTATIONHALLMARKSGLUTAMINEHYPOXIACELLS
제목
Design, Synthesis and Biological Evaluation of Novel MDH Inhibitors Targeting Tumor Microenvironment
저자
Godesi, SreenivasuluHan, Jeong-RanKim, Jang-KeunKwak, Dong-IkLee, JoohanNada, HossamKim, MinkyoungYang, Hyun-AIm, Joo-YoungBan, Hyun SeungLee, Chang HoonChoi, YongseokWon, MisunLee, Kyeong
DOI
10.3390/ph16050683
발행일
2023-05
유형
Article
저널명
Pharmaceuticals
16
5
페이지
1 ~ 35